What factors should a lab consider before purchasing a preclinical imaging system?

Evaluate throughput requirements, modality compatibility with primary research applications, total cost of ownership including service contracts, and facility infrastructure such as shielding and ventilation. A site visit to a comparable installation is recommended before committing capital [17]. Read More

How do CRO imaging services compare to in-house preclinical imaging cores on a per-study cost basis?

CRO per-study fees typically range from USD 5,000 to USD 25,000 depending on modality and protocol complexity, whereas in-house cores require USD 2–5 million in upfront capital plus annual maintenance [10]. Breakeven favors in-house operation above roughly 150 studies per year. Read More

Which emerging radioisotopes are driving new demand for preclinical nuclear imaging equipment?

Actinium-225, Terbium-161, and Copper-64 are gaining traction in theranostic development programs and require detector sensitivities and energy windows that older SPECT systems cannot accommodate [14]. Upgraded digital-detector platforms address these isotope requirements. Read More

How does photoacoustic imaging fit into the preclinical modality landscape?

Photoacoustic imaging bridges optical contrast with ultrasound resolution, enabling label-free hemoglobin and oxygen-saturation mapping at depths of 2–3 cm [25]. Adoption is concentrated in cardiovascular and tumor-microenvironment research. Read More

What role does regulatory harmonization play in shaping equipment procurement decisions?

FDA and EMA alignment on imaging-endpoint qualification would let sponsors standardize protocols across geographies, reducing redundant equipment purchases [13]. Progress has been slow but directionally positive since 2023. Read More

Are refurbished preclinical imaging systems a viable option for budget-constrained labs?

Refurbished micro-CT and optical systems can cost 40–60% less than new units and are increasingly available from certified resellers with 12-month warranties [17]. Performance parity depends on detector age and software upgrade eligibility. Read More

How is cloud connectivity changing preclinical imaging data management?

Cloud platforms enable centralized storage, multi-site protocol standardization, and remote expert review, reducing local IT burden [7]. Data sovereignty regulations in the EU may require regional hosting configurations. Read More

Preclinical Imaging Market (2026 - 2035)

Preclinical Imaging Market Research Report Information By Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, and Photoacoustic Imaging System), By Distribution Channel (Optical, Nuclear, CT Contrast Agents, and MRI Contrast Agents), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2026-2035

CAGR

5.10%

2025 Market Size

USD 4.73 Billion (2025)

2035 Market Size

USD 7.78 Billion (2035)

Medical Device ● Updated August 24, 2026 Report ID: MRFR/MED/5896-HCR | Pages: 110 | Author: Vikita Thakur, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Pharmaceutical R&D Spending | |
  2. 3.1.2 AI and Machine-Learning Integration | |
  3. 3.1.3 CRO Outsourcing Trend | |
  4. 3.1.4 Government Imaging Infrastructure Grants | |
  5. 3.1.5 3Rs Regulatory Pressure Favoring Non-Invasive Imaging | |
  6. 3.1.6 Expansion of Immuno-Oncology and Cell-Therapy Pipelines | |
  7. 3.1.7 Emerging-Market Academic Lab Modernization |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Capital Cost of Multimodal Systems | |
  2. 3.2.2 Shortage of Trained Imaging Scientists | |
  3. 3.2.3 Regulatory Uncertainty on Imaging Endpoints | |
  4. 3.2.4 Long Procurement Cycles at Academic Institutions | |
  5. 3.2.5 Animal-Use Ethical Restrictions Limiting Study Volumes |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Imaging-as-a-Service and Subscription Models | |
  2. 3.3.2 Theranostics-Driven Demand for Nuclear Imaging | |
  3. 3.3.3 Emerging-Market Infrastructure Build-Out | |
  4. 3.3.4 Data Monetization Through Imaging Repositories | |
  5. 3.3.5 3Rs-Compliant Longitudinal Imaging Replacing Terminal Studies |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Preclinical Imaging Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Modality | |
  1. 5.1.1 Optical Imaging Systems | |
  2. 5.1.2 Nuclear Imaging Systems | |
  3. 5.1.3 Micro-MRI | |
  4. 5.1.4 Micro-CT | |
  5. 5.1.5 Hybrid / Multimodal |
2. 5.2 By Application | |
  1. 5.2.1 Oncology | |
  2. 5.2.2 Neurology | |
  3. 5.2.3 Cardiovascular Disorders | |
  4. 5.2.4 Other Applications |
3. 5.3 By End User | |
  1. 5.3.1 Pharmaceutical & Biotechnology Companies | |
  2. 5.3.2 Contract Research Organizations | |
  3. 5.3.3 Academic & Government Research Institutes | |
  4. 5.3.4 Other End Users
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Bruker Corporation | |
  2. 7.3.2 Revvity (formerly PerkinElmer) | |
  3. 7.3.3 Siemens Healthineers | |
  4. 7.3.4 MILabs (Rigaku) | |
  5. 7.3.5 Mediso Medical Imaging Systems | |
  6. 7.3.6 Fujifilm VisualSonics | |
  7. 7.3.7 MR Solutions | |
  8. 7.3.8 Li-Cor Biosciences | |
  9. 7.3.9 Molecubes | |
  10. 7.3.10 Aspect Imaging
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Autonomous Imaging Workflows |
2. 8.2 Platform Economics and Software-Defined Scanners |
3. 8.3 Radiopharmaceutical and Cell-Therapy Supercycle |
4. 8.4 ESG and Sustainability Reporting in Animal Research
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Preclinical Imaging Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Preclinical Imaging Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Preclinical Imaging Market – Driver Impact Analysis |
TABLE 4 Global Preclinical Imaging Market – Restraint Impact Analysis |
TABLE 5 Global Preclinical Imaging Market Size, by Modality, 2021–2035 (USD Billion) |
TABLE 6 Global Preclinical Imaging Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 7 Global Preclinical Imaging Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 8 Global Preclinical Imaging Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 9 North America Preclinical Imaging Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Europe Preclinical Imaging Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Asia-Pacific Preclinical Imaging Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 South America Preclinical Imaging Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Middle East & Africa Preclinical Imaging Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Competitive Benchmarking Matrix – Global Preclinical Imaging Market, 2025 |
TABLE 15 Company Profiles – Key Players, Global Preclinical Imaging Market |
TABLE 16 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 17 Report Scope & Methodology Summary |
TABLE 18 Detailed Sources and Citations |
TABLE 19 North America Preclinical Imaging Market Size, by Modality, 2021–2035 (USD Billion) |
TABLE 20 North America Preclinical Imaging Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 21 North America Preclinical Imaging Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 22 Europe Preclinical Imaging Market Size, by Modality, 2021–2035 (USD Billion) |
TABLE 23 Europe Preclinical Imaging Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 24 Europe Preclinical Imaging Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 25 Asia-Pacific Preclinical Imaging Market Size, by Modality, 2021–2035 (USD Billion) |
TABLE 26 Asia-Pacific Preclinical Imaging Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 27 Asia-Pacific Preclinical Imaging Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 28 South America Preclinical Imaging Market Size, by Modality, 2021–2035 (USD Billion) |
TABLE 29 South America Preclinical Imaging Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 30 South America Preclinical Imaging Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 31 Middle East & Africa Preclinical Imaging Market Size, by Modality, 2021–2035 (USD Billion) |
TABLE 32 Middle East & Africa Preclinical Imaging Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 33 Middle East & Africa Preclinical Imaging Market Size, by End User, 2021–2035 (USD Billion)
13 LIST OF FIGURES |
FIGURE 1 Preclinical Imaging Market Dynamics Overview |
FIGURE 2 Industry Value Chain Analysis – Preclinical Imaging Market |
FIGURE 3 Porter's Five Forces Analysis – Preclinical Imaging Market |
FIGURE 4 Global Preclinical Imaging Market Size Trend & Forecast (USD Billion), 2021–2035 |
FIGURE 5 Preclinical Imaging Market Share, by Modality (%), 2025 |
FIGURE 6 Preclinical Imaging Market Share, by Application (%), 2025 |
FIGURE 7 Preclinical Imaging Market Share, by End User (%), 2025 |
FIGURE 8 Preclinical Imaging Market Share, by Region (%), 2025 |
FIGURE 9 North America Preclinical Imaging Market Size Trend (USD Billion), 2021–2035 |
FIGURE 10 Europe Preclinical Imaging Market Size Trend (USD Billion), 2021–2035 |
FIGURE 11 Asia-Pacific Preclinical Imaging Market Size Trend (USD Billion), 2021–2035 |
FIGURE 12 South America Preclinical Imaging Market Size Trend (USD Billion), 2021–2035 |
FIGURE 13 Middle East & Africa Preclinical Imaging Market Size Trend (USD Billion), 2021–2035 |
FIGURE 14 Competitive Landscape – Market Share Analysis, 2025 |
FIGURE 15 Competitive Benchmarking Radar Chart – Top 10 Players

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
Modality	Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-CT, Hybrid / Multimodal	Optical Imaging Systems	Hybrid / Multimodal
Application	Oncology, Neurology, Cardiovascular Disorders, Other Applications	Oncology	Neurology
End User	Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Government Research Institutes, Other End Users	Pharmaceutical & Biotechnology Companies	Contract Research Organizations
Geography	North America, Europe, Asia-Pacific, South America, Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Modality

Sub-Segment	Key Trend
Optical Imaging Systems	Fluorescence and bioluminescence platforms dominate installed base; cloud-connected analytics expanding
Nuclear Imaging Systems	Theranostics pipeline driving PET/SPECT demand; new radioisotope compatibility requirements
Micro-MRI	Cryogen-free compact systems lowering infrastructure barriers; neurology application growth
Micro-CT	Fast-scan protocols enabling high-throughput phenotyping; spectral CT emerging
Hybrid / Multimodal	Co-registered PET/MRI and PET/CT/SPECT trimodal platforms gaining translational adoption

Modality selection in the Preclinical Imaging Market is increasingly driven by multi-program versatility rather than single-application performance. Labs that serve diverse therapeutic-area portfolios are gravitating toward hybrid configurations that maximize scanner utilization across oncology, neurology, and cardiovascular programs within a single capital investment.

By Application

Sub-Segment	Key Trend
Oncology	Immuno-oncology and ADC pipelines sustaining highest imaging study volumes
Neurology	Amyloid, tau, and neuroinflammation tracer development accelerating micro-PET and MRI demand
Cardiovascular Disorders	Cardiac MRI and photoacoustic imaging enabling non-invasive hemodynamic assessment
Other Applications	Infectious disease, metabolic disorders, and musculoskeletal research expanding modality utilization

Oncology remains the backbone of preclinical imaging demand, but the rapid growth in neurology-focused imaging reflects broader pharmaceutical industry investment in neurodegeneration. Cardiovascular applications benefit from non-invasive longitudinal protocols that align with 3Rs-compliant study designs.

By End User

Sub-Segment	Key Trend
Pharmaceutical & Biotechnology Companies	Maintaining in-house multi-modality cores to support large pipeline portfolios
Contract Research Organizations	Investing aggressively in GLP-compliant imaging capacity; fastest-growing channel
Academic & Government Research Institutes	Grant-funded shared cores driving optical and MRI installations
Other End Users	Diagnostic companies and medical-device firms using imaging for product validation

The end-user landscape in the Preclinical Imaging Market is shifting as CROs capture an increasing share of imaging study volume from sponsors seeking capital-light R&D models. Academic institutions remain critical for technology adoption and training, while pharma companies anchor the highest per-site revenue contribution.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”